Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8851 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8141 |
Intermediate Similarity |
NPD6385 |
Approved |
0.8141 |
Intermediate Similarity |
NPD6386 |
Approved |
0.8101 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.805 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7975 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7975 |
Intermediate Similarity |
NPD37 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7961 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7952 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.795 |
Intermediate Similarity |
NPD919 |
Approved |
0.7937 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7937 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7937 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7882 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD7472 |
Approved |
0.784 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7815 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7806 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7758 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7746 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7714 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD17 |
Approved |
0.7673 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD920 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7582 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7564 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7561 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD2798 |
Approved |
0.755 |
Intermediate Similarity |
NPD447 |
Suspended |
0.755 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7532 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7228 |
Approved |
0.75 |
Intermediate Similarity |
NPD9494 |
Approved |
0.75 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6190 |
Approved |
0.745 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7436 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7421 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7362 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7351 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5978 |
Approved |
0.733 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7312 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7292 |
Intermediate Similarity |
NPD9545 |
Approved |
0.729 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7183 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD7235 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7143 |
Intermediate Similarity |
NPD943 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7125 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1358 |
Approved |
0.711 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7066 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD3750 |
Approved |
0.705 |
Intermediate Similarity |
NPD3134 |
Approved |
0.703 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7022 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD3266 |
Approved |
0.702 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7011 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD5647 |
Approved |
0.6974 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6972 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6964 |
Remote Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6951 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3142 |
Approved |
0.6923 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD3140 |
Approved |
0.6919 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6908 |
Remote Similarity |
NPD1203 |
Approved |
0.6903 |
Remote Similarity |
NPD3268 |
Approved |
0.6898 |
Remote Similarity |
NPD6781 |
Approved |
0.6898 |
Remote Similarity |
NPD6782 |
Approved |
0.6898 |
Remote Similarity |
NPD6780 |
Approved |
0.6898 |
Remote Similarity |
NPD6777 |
Approved |
0.6898 |
Remote Similarity |
NPD6778 |
Approved |
0.6898
|
Remote Similarity |
NPD6779 |
Approved |